Advertisement

Nalbuphine Injection

[17 September 2014]

Products Affected - Description

Nalbuphine injection, Hospira
10 mg/mL, 1 mL ampules (NDC 00409-1463-01)

Reason for the Shortage

  • Endo discontinued Nubain in 2008.
  • Teva discontinued all nalbuphine injections in July, 2010.
  • Hospira has nalbuphine on shortage due to manufacturing delays.

Available Products

Nalbuphine injection, Hospira
10 mg/mL 10 mL vials (NDC 00409-1464-01)
20 mg/mL 10 mL vials (NDC 00409-1467-01)
20 mg/mL 1 mL ampules (NDC 00409-1465-01)

Estimated Resupply Dates

Hospira has nalbuphine 10 mg/mL 1 mL ampules on back order and the company estimates a release date of mid-December 2014.

Related Shortages

Updated

September 17, 2014; June 26, 2014; April 30, 2014; March 13, 2014; January 3, 2014; November 1, 2013; October 18, 2013; October 7, 2013; September 4, 2013; August 9, 2013; July 2, 2013; June 10, 2013; May 30, 2013; May 9th, 2013; April 1, 2013; March 5, 2013; February 22, 2013; January 21, 2013; December 31, 2012; December 10, 2012; November 28, 2012; October 24, 2012; September 13, 2012; May 15, 2012; May 8, 2012; March 29, 2012; March 12, 2012; January 9, 2012; December 7, 2011; June 29, 2011; May 26, 2011; May 11, 2011; April 18, 2011; April 7, 2011; March 24, 2011; February 22, 2011; February 3, 2011; January 28, 2011; December 22, 2010; November 22, 2010; November 8, 2010; November 4, 2010; November 3, 2010; October 21, 2010; October 12, 2010; September 30, 2010; September, 14, 2010; September 2, 2010; August 20, 2010; July 20, 2010, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement